Desketoraloxifene

CAS No. 216570-81-9

Desketoraloxifene( —— )

Catalog No. M23980 CAS No. 216570-81-9

Desketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 272 In Stock
10MG 409 In Stock
25MG 737 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Desketoraloxifene
  • Note
    Research use only, not for human use.
  • Brief Description
    Desketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).
  • Description
    Desketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    PLD1|PLD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    216570-81-9
  • Formula Weight
    445.57
  • Molecular Formula
    C27H27NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CCN(CC1)CCOC2=CC=C(C=C2)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Scott S A , Spencer C T , MC O’Reilly, et al. Discovery of Desketoraloxifene Analogues as Inhibitorsof Mammalian, Pseudomonas aeruginosa, and NAPE PhospholipaseD Enzymes[J]. Acs Chemical Biology, 2015, 10(2):421.
molnova catalog
related products
  • Tris(2,4-di-tert-but...

    Tris(2,4-di-tert-butylphenyl)phosphate is a natural compound isolated from Vitex negundo L. with anti-inflammatory activity.

  • BIRM 271

    BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.

  • CCT129957

    CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.